Showing posts with label pulmonary hypertension. Show all posts
Showing posts with label pulmonary hypertension. Show all posts

Friday, October 18, 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.


Adempas drug gets FDA approval for treatment of pulmonary hypertension